RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Regulatory Update

Regulatory Update

Posted 01 November 2010 | By

In this Issue
  • FDA Issues Draft Guidance for When an IND Is Required
  • Live Biotherapeutic Products Clinical Trial Guidance Available
  • EMA Becomes More Transparent Regarding Document Access and Conflicts of Interest

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.